See also this year's filing and all EDGAR filings for this company.
PDF Report 0001466301_2021_Clovis_Oncology_Inc.pdf
Logs
| info | Minor missing amount for aggregate added to remainder | industry.us_generic | {'aggregate': 'Expenses', 'missing_ratio': 0.09722071845181214, 'aggregate_val': 466163000, 'exp_sum': 424858000, 'exp_to_value': {'CostOfGoodsAndServicesSold': 0, 'SellingGeneralAndAdministrativeExpense': 163894000, 'ResearchAndDevelopmentExpense': 257707000, 'remainder_Expenses': 3257000}} |
Graph
Absolute values for 0001466301, Clovis Oncology Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 310,829,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 128,817,000 |
| 2 | PropertyPlantAndEquipmentNet | 12,085,000 |
| 3 | remainder_Assets | 153,823,000 |
| 4 | LiabilitiesCurrent | 184,928,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 579,374,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 163,894,000 |
| 9 | ResearchAndDevelopmentExpense | 257,707,000 |
| 10 | remainder_Expenses | 44,562,000 |
| 11 | remainder_Revenues | 164,522,000 |
| 12 | remainder_NetIncome | -67,571,000 |
| 13 | remainder_ComprehensiveNetIncome | 561,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 605,554,000 |
| 1 | Liabilities | 764,302,000 |
| 2 | Expenses | 466,163,000 |
| 3 | Revenues | 164,522,000 |
| 4 | StockholdersEquity | -158,748,000 |
| 5 | NetIncome | -369,212,000 |
| 6 | ComprehensiveNetIncome | -368,931,500 |
| 7 | BaseVar | 1,034,336,500 |
| 8 | EconomicCapitalRatio | -0.937 |
Edgar->Model Mapping
Feature Distribution
Change over Time
